Last updated on April 18, 2014 at 13:24 EDT

Regeneron Announces Upcoming 2013 Investor Conference Presentations

August 27, 2013

TARRYTOWN, N.Y., Aug. 27, 2013 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences:

    --  Morgan Stanley Global Healthcare Conference on Monday, September 9,
        2013.  The presentation is scheduled for 2:25 p.m. Eastern Time.
    --  Baird's 2013 Healthcare Conference on Tuesday, September 10, 2013.  The
        presentation is scheduled for 1:10 p.m. Eastern Time.

The presentations may be accessed through the Company’s web site, www.regeneron.com, on the ‘Events and Presentations’ page. An archived version of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals

Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, allergic asthma, and atopic dermatitis. For additional information about the company, please visit www.regeneron.com.

    Contact Information:

    Manisha Narasimhan, Ph.D.        Peter Dworkin

    Investor Relations               Corporate Communications

    914.847.5126                     914.847.7640

    manisha.narasimhan@regeneron.com peter.dworkin@regeneron.com

SOURCE Regeneron Pharmaceuticals, Inc.

Source: PR Newswire